Serum Interleukin-13 and Caspase 8 are Elevated in Prurigo Nodularis

Predictive biomarker modeling of pediatric atopic dermatitis severity based on longitudinal serum collection

(2022) Sarah M Engle et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Mechanistic insights into the antipruritic effects of lebrikizumab, an anti–IL-13 mAb

(2022) Yannick Miron et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Regulation of Caspase-8 Activity at the Crossroads of Pro-Inflammation and Anti-Inflammation

(2021) Jun-Hyuk Han et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Prurigo Nodularis Is Characterized by Systemic and Cutaneous T Helper 22 Immune Polarization

(2021) Micah Belzberg et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata

(2021) Özge Aşkın et al.   ANAIS BRASILEIROS DE DERMATOLOGIA

The pruritogenic role of the type 2 immune response in diseases associated with chronic itch

(2021) Giuseppe Ingrasci et al.   EXPERIMENTAL DERMATOLOGY

Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab

(2021) Lam C. Tsoi et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Prurigo Nodularis: Pathogenesis and Management

(2020) Kyle A. Williams et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Decreased serum levels of interleukin‐17, interleukin‐23, TGF ‐β in pemphigus vulgaris patients and their association with disease phase

(2020) Zeinab Gholibeigian et al.   Dermatologic Therapy

The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond

(2018) Nicolo Costantino Brembilla et al.   Frontiers in Immunology